Introduction
============

The Pacific oyster *Crassostrea gigas* is a marine invertebrate belonging to the family *Ostreidae* (Mollusca, Bivalvia) with a worldwide distribution from Japan to occidental countries in Europe and America (Guo et al., [@B43]). Oysters are filter-feeders cultured in bays, lagoons, and estuaries (Buestel et al., [@B10]; Dumbauld et al., [@B23]) where they are exposed to abundant and changing microbial communities. To date, the oyster-associated microflora, which in some regions of the world includes human pathogens, has been essentially studied for food safety purposes. Although the microbial communities associated to healthy oysters remain poorly studied, they were shown to be abundant and to vary with environmental conditions. This abundance in non-diseased animals could be relevant of a protective function and raises several questions on oyster biology, immunity, and homeostasis: Does an oyster-specific microbial community exist? How does the oyster microflora coexist with immunocompetent cells in the circulatory system? How can the oyster immune system discriminate between pathogens and commensals? In invertebrates, pathogen recognition, and disease control are mediated by an innate immune system, in which reactive oxygen species (ROS) and antimicrobial peptides play a key defense function (Lemaitre and Hoffmann, [@B72]). In this review, we give a brief summary on oyster environmental and resident microflora and present a state of the art on the antimicrobial defense of *C. gigas* oysters, its regulation, diversity, and its molecular effectors, with a special focus on the antimicrobial peptides and proteins.

Oysters and the Environmental Microflora
========================================

The health status of marine organisms is uniquely related to their immediate environments, which can contain very high concentrations of microorganisms. When conditions become favorable for multiplication, both the saprophytic and pathogenic microorganisms from their environment are capable of infecting marine organisms (Ellis, [@B26]). However, under normal conditions, marine invertebrates like oysters maintain a healthy status by defending themselves against these potential invaders using a repertoire of innate defenses (Bachère et al., [@B6]; Schmitt et al., [@B102]).

The environmental microflora in lagoons and estuaries
-----------------------------------------------------

Human activities are concentrated along the coasts worldwide. As a result, marine coastal systems are under increasing anthropic and environmental pressures. The high densities of human populations along the coasts as well as the human exploitation of the sea, lagoons, and estuaries for recreational activities, fishing, and shellfish farming are important factors that modify marine coastal systems. Moreover, due to the shallow water of these systems, they are highly impacted by seasonal variations and long term climate changes. Thus, both drastic and rapid changes are observed in sea water temperature, salinity, oxygenation, sunlight, pH, and content in organic matter. Those variations, which occur both temporarily and spatially, influence the viability/culturability, the abundance, and the ecology of bacteria (Pruzzo et al., [@B90]).

For instance, changes in the microflora of lagoons resulting from human activities have been observed following major rain events with a massive input in fecal coliforms and streptococci. It was shown that floods massively drained bacteria entrapped in the sediment of coastal rivers down to the lagoons (Chu et al., [@B16]). Additional sources of bacterial loads during rainfall events were also attributed to overflow from sewage systems and the failure of septic tanks (Al Bakri et al., [@B1]; Astrom et al., [@B2]).

Such natural events not only modify the abundance but also the composition of the coastal microflora by favoring the development of natural inhabitants of coastal sea waters better adapted to a given salinity or temperature. Thus, vibrios, which are autochthonous in riverine, estuarine, and coastal waters throughout both temperate and tropical regions of the world, are highly dependent on environmental parameters such as temperature, salinity, concentration of organic matter and the presence of chitinous organism (e.g., zooplankton), which are in turn controlled by larger-scale climate variability (Lipp et al., [@B74]). For instance, the prevalence of the human pathogen *Vibrio cholerae* is inversely correlated with salinity (Jiang, [@B56]), and a statistically significant relationship could be established between the time series for cholera and rainfall anomalies (Constantin de Magny et al., [@B19]).

Numerous surveys of coastal marine systems have shown that temperature is favoring the spread of vibrios including species pathogenic for marine invertebrates. Thus, as a consequence of ocean warming, *Vibrio*-associated diseases have increased causing mass mortalities in both wild and farmed species of marine invertebrates such as corals (Vezzulli et al., [@B118]), abalone (Travers et al., [@B115]), and oysters (Garnier et al., [@B31]). It is still difficult to determine how far the increase of the *Vibrio* load in marine coastal water contributes to animal disease. Indeed, environmental factors such as temperature also modulate the virulence status of bacteria (Vezzulli et al., [@B118]) and the physiological status of the animal species cultured in these systems, in particular oysters, whose reproductive status is dependent on an elevated sea water temperature.

Oyster commensal microflora and homeostasis
-------------------------------------------

Animals including marine invertebrates carry numerous species of bacteria and it is becoming increasingly clear that most of these microorganisms constitute a host-specific community. However, we understand relatively little about the mechanisms involved in the reciprocal host--bacterial signaling because of the multiple interactions existing between and among the typically multispecies microbial consortia of animals (Ruby, [@B98]).

As filtering animals, oysters need high volumes of water for their nutrition and respiration. Consequently, they are in continuous contact with abundant microorganisms from their marine environment, which include both pathogens and commensals. Generally, oyster body surfaces harbor a dense and diverse natural microbiota, dominated by Gram-negative bacteria of the genera *Pseudomonas* and *Vibrionaceae* (Ortigosa et al., [@B85]). Like the human gut, oyster bacteria-enriched epithelia offer a naturally competitive environment that can prevent the establishment of potential pathogens (Salzman et al., [@B100]). Surprisingly, in healthy oysters, many organs inside the body, including the hemolymph, are also populated by a natural microbiota. Among others, it is composed of species from the genus *Vibrio*, *Pseudomonas*, *Flavobacterium*, *Cytophaga*, *Bacillus*, and *Micrococcus* (Lauckner, [@B68]; Paillard et al., [@B87]).

The existence of a host-specific microflora in oysters is still questioned. The microflora associated to oysters varies according to the environmental microflora. Thus, depuration, which is used after collection and prior to commercialization of oysters, results in a major decrease of coliforms and other transient residents of oyster tissues. However, bacterial communities in oyster hemolymph and surrounding sea water display different composition (de Lorgeril et al., unpublished data), indicating the existence of communities better adapted to oyster hemolymph (see below). Among these, the *Vibrio* species, which have a long co-evolution story with marine invertebrates resist rather efficiently to depuration procedures of edible bivalves, having a worldwide incidence on *Vibrio*-related seafood-borne diseases (Pruzzo et al., [@B90]). Pruzzo et al. ([@B90]) therefore proposed that this resistance to depuration could indicate that vibrios belong to the persistent microflora of oysters.

Homeostasis is the maintenance of a stable state within the body in response to a changing external environment. Without homeostasis, no life form could adapt to their environment. Therefore, maintaining this equilibrium is essential for any organism to remain healthy and stay alive. As mentioned above, the oyster environment is subjected to drastic and rapid changes. Therefore, oysters must have an efficient system to maintain homeostasis. Oyster homeostasis is maintained through layered defenses. The first line of defense is determined by physical protective barriers that prevent damage of the underlying tissues and infections by pathogenic microorganisms. The main physical barriers are the shell and mucus (Glinski and Jarosz, [@B34]). However, when pathogens breach these protective barriers, they must confront the oyster immune response. For this, oysters have developed complex mechanisms of recognition and immune regulation to discriminate advantageous microorganisms from pathogenic ones, control infections, and maintain homeostasis.

It is generally assumed that the circulatory system of healthy animals is sterile, whereas the presence of bacteria is considered as infection. The abundant microflora of healthy oysters is therefore puzzling. The coexistence of immunocompetent cells and microorganisms in the circulatory system of oysters appears intriguing and impressive. It has undoubtedly been decisive for the evolution of the oyster immune system and its interaction with pathogens. One can assume that the oyster microflora plays a protective role by stimulating oyster immunity and/or competing with potential pathogens, and is therefore essential for the maintenance of homeostasis. The production of antimicrobial peptides (bacteriocins) is widespread in bacteria associated to marine organisms (Desriac et al., [@B21]). Together with the host antimicrobial defenses, which themselves are enhanced upon pathogen recognition (see immune responses section), antimicrobials from bacterial origin likely have a protective effect against pathogens. Thus, as in corals, a dynamic relationship between commensal microorganisms and oysters could select for a holobiont (host and associated microorganisms) better suited for resistance to specific pathogens. This probiotic hypothesis has been referred to as the hologenome theory of evolution (Rosenberg et al., [@B95]).

Infectious agents and diseases in oysters
-----------------------------------------

While oyster-associated microorganisms can be significantly beneficial for the maintenance of oyster homeostasis, some can be highly virulent for given species of oysters resulting in massive mortalities or even the extinction of some oyster populations. Oyster pathogens include protozoans, viruses, and bacteria, which affect all stages of development, from larvae to juveniles and adult oysters (for review see Schmitt et al., [@B102]).

Considering bacteria, the difficulties encountered in identifying the pathogenic ones are due to the normal accumulation of a very rich bacterial commensal microbiota composed of different species. Some of these bacteria, mainly opportunistic and pathogenic, eventually colonize and invade the host, depending on the environmental factors influencing host--bacteria interactions (Paillard et al., [@B87]). As an example, oyster mortalities are frequently associated to the presence of bacterial pathogens of the *Vibrio* genus, particularly strains of *V. splendidus* and *V. aestuarianus* (Le Roux et al., [@B70]; Garnier et al., [@B32]). However, it remains unclear whether these bacteria act as primary pathogens or as opportunists (Paillard et al., [@B87]). Besides, many vibrios potentially pathogenic to humans, inhabitants of coastal waters, are found in bivalves and can be transmitted to humans through their raw consumption. Those human pathogens do not cause disease in oyster and are likely normal residents of the oyster microflora. The ability of *Vibrio* species to persist within oyster tissues is responsible for their high concentration within this host that can act as an environmental reservoir of human pathogens (Pruzzo et al., [@B90]).

Oyster Immune Defenses
======================

Oyster immune cells
-------------------

As marine invertebrates, oysters have an immune system that resembles the innate immune system of vertebrates (for review see Schmitt et al., [@B102]). In oysters, both hemocytes (circulating blood cells) and surface epithelia display immune functions, expressing both non-self recognition receptors and immune effectors involved in the control of the resident/pathogenic microflora. Still, to date, most of the studies have been dedicated to the description of hemocyte immune functions.

Oysters possess a semi-open circulatory system where the blood, called hemolymph, flows largely through a system of sinuses. The hemolymph bathes the organs directly providing oxygen and nutrients, and is composed of fluid plasma and hemocytes. The circulatory system contributes to the hemocyte ability to migrate toward connective tissues (Figure [1](#F1){ref-type="fig"}). They migrate by diapedesis from blood sinuses and vessels to the surface body, particularly to surface epithelia such as mantle and gills (Cheng, [@B14]).

![**A not-to-scale schematic illustration of oyster antimicrobial defenses**. Oyster epithelial surfaces are in contact with an abundant microflora that can offer a competitive environment that prevents the establishment of potential pathogens. In healthy oysters, surface epithelia constitutively express AMPs, which also contribute to prevent invasion by pathogens. Upon wounding or infection, damage- or pathogen-associated molecular patterns trigger hemocyte infiltration to the site of infection. Infiltrating hemocytes serve as vehicles for AMP families that display synergistic activities with AMPs from epithelial surfaces. Upon recognition by pattern recognition receptors/proteins, microorganisms present in tissues and hemolymph can also be phagocytosed and further eliminated by the production of reactive oxygen species (ROS), hydrolytic enzymes, and AMPs. It is still unknown whether AMP-containing hemocyte granules fuse with the phagosome, undergo exocytosis or both.](fmicb-03-00160-g001){#F1}

The classification of oyster hemocytes has been the subject of extensive studies since early 1970s. Based on different criteria (morphology, ultrastructure, physicochemical features, biological functions), they have been classified into main two cell types (granular and agranular cells), which are subdivided into several subgroups (Cheng, [@B13]; Hine, [@B45]; Bachère et al., [@B6]). Whereas granulocytes form a distinct group composed of both basophilic and eosinophilic granulocytes, agranular hemocytes are heterogeneous in appearance and ultrastructure, characterized by the absence or the presence of few cytoplasmic granules (Bachère et al., [@B5]). Three types of agranular hemocytes have been identified: blast-like cells, basophilic macrophage-like cells, and hyalinocytes. However, the distinction between types and/or lineages, the origin, maturation, and the life span of oyster hemocytes has never been demonstrated.

At present, there is considerable information about the role of hemocytes in oyster defense. Hemocytes are capable of non-self recognition, chemotaxis, and active phagocytosis (Cheng, [@B13]; Bachère et al., [@B6]). They are implicated in cytotoxic reactions by the production of hydrolytic enzymes (Cheng and Rodrick, [@B15]), ROS (Bachère et al., [@B3]; Lambert et al., [@B66]) and antimicrobial peptides/proteins (Gueguen et al., [@B41], [@B42]; Gonzalez et al., [@B35],[@B36]; Rosa et al., [@B94]). They also produce soluble factors to protect oyster against infections (Rinkevich and Muller, [@B91]; Pruzzo et al., [@B90]). Thus, as immunocompetent cells, infiltrating hemocytes are present in all cavities and tissues of oyster body where they can be able to phagocyte and to destroy infectious agents.

Although less studied for their immune functions, surface epithelial cells also express receptors dedicated to pathogen recognition (Itoh and Takahashi, [@B53]) as well as hydrolytic enzymes (Matsumoto et al., [@B79]; Itoh and Takahashi, [@B52]; Itoh et al., [@B55], [@B50]; Xue et al., [@B121]) and antimicrobial peptides/proteins involved in the control of infections (Gueguen et al., [@B41]; Gonzalez et al., [@B36]).

Immune responses
----------------

Recent advance in our knowledge of the oyster immune response has been made through the development of genomic-based approaches (Gueguen et al., [@B40]; Tanguy et al., [@B109]; Fleury et al., [@B28]; Lang et al., [@B67]; Roberts et al., [@B92]; Taris et al., [@B110]; de Lorgeril et al., [@B20]). The main defense mechanisms described in oysters have been recently reviewed in (Schmitt et al., [@B102]). They include: (i) recognition of microbe/pathogen-associated molecular patterns (M/PAMPs) or damage-associated molecular patterns (DAMPs) by both soluble and cellular pattern recognition receptors/proteins (PRRs and PRPs), (ii) hemocyte signaling and activation, (iii) hemocytes mediated reactions (phagocytosis, encapsulation, and tissue infiltration), and (iv) production of reactive species of oxygen and nitrogen and host defense molecules (Figure [1](#F1){ref-type="fig"}).

*Recognition* is mediated by a series of PRPs and PRRs. In oysters, the known PRPs/PRRs include peptidoglycan recognition proteins (PGRPs), which recognize specifically peptidoglycans (PG) from bacteria (Itoh and Takahashi, [@B53]), carbohydrate-binding proteins such as the β-1,3-glucan binding protein (βGBP), which binds to β-1,3-glucans from fungi cell walls (Tanguy et al., [@B109]; Itoh and Takahashi, [@B54]) and lectins (gigalins, C-type lectins, ficolins, and galectins) (Olafsen et al., [@B84]; Gueguen et al., [@B40]; Tasumi and Vasta, [@B111]; Yamaura et al., [@B122]). Over expression of C-type lectins and a rhamnospondin-like ([l]{.smallcaps}-rhamnose-binding lectin) in *C. gigas* hemocytes has been associated to a successful immune response to an experimental infection with virulent *Vibrio* strains as compared to an infection with an avirulent *Vibrio* (de Lorgeril et al., [@B20]). Additionally to those classical PRPs/PRRs, other proteins were also described as participating in oyster non-self recognition by their LPS-binding properties. These include the major plasma protein Cu/Zn extracellular superoxide dismutase (*Cg*-EcSOD) and the antimicrobial protein *Cg*-BPI for bactericidal/permeability-increasing (BPI) protein that will be further discussed below (Gonzalez et al., [@B37], [@B36]).

*Intracellular signaling* cascades are initiated upon M/PAMP or DAMP recognition. Highly conserved in the animal kingdom, one major signaling cascade identified in oyster is the NF-κB pathway (for review see Schmitt et al., [@B102]). In *Drosophila*, it plays a major role in the regulation of the antimicrobial response (Lemaitre and Hoffmann, [@B72]). In oysters, although many elements of the NF-κB pathway have been identified, its direct role in immunity remains unexplored. Signaling events induce several defense responses, such as hemocyte activation, migration, and the expression of immune mediators that elicit defense reactions which coordinate the elimination of pathogens and infected cells. Some families of oyster antimicrobial peptides/proteins including big defensins and BPI protein are among the known effectors of oyster immunity that respond to a microbial challenge or an injury (see [Regulation of AMP Expression in Healthy and Diseased Animals](#s1){ref-type="sec"}). Nonetheless, the signaling cascades controlling their gene expression are still unknown.

*The control of pathogens* relies on a combination of cellular and molecular defenses. Thus, following injury, hemocytes are recruited massively toward the sites of infection where they contribute to a local defense (Cochennec-Laureau et al., [@B17]; Bachère et al., [@B6]). Hemocyte migration leads to a local concentration of immune effectors likely to prevent host invasion (Schmitt et al., [@B101]). May invasion occur, circulating hemocytes are capable of readily initiating phagocytosis as a major defense reaction in oyster (Figure [1](#F1){ref-type="fig"}). The crucial role of phagocytosis in *C. gigas* immune response has been highlighted by the overrepresentation of transcripts of phagocytosis-related genes in hemocytes of oysters surviving infections by virulent *Vibrio* strains as compared to oysters receiving the same doses of an avirulent *Vibrio* (de Lorgeril et al., [@B20]). Not surprisingly, phagocytosis is consequently either avoided by extracellular pathogens such as *V. aestuarianus* (Labreuche et al., [@B63],[@B64]) or impaired in elimination of intracellular pathogens such as *V. splendidus* (Duperthuy et al., [@B25]).

To be phagocytosed, the foreign agent is opsonized by plasma molecules and further engulfed within a phagosome. As soon as they come in contact with hemocyte membranes, phagocytosed microorganisms are exposed to the respiratory burst, a major microbicidal reaction in oysters (see below). The phagosome maturation then leads to acidification and fusion with cytoplasmic vesicles/granules (including lysosomes), which in oyster were shown to contain diverse families of antimicrobial peptides/proteins (Gueguen et al., [@B42]; Schmitt et al., [@B101]). The release into the phagosome of this arsenal of microbicidal compounds leads to the rapid neutralization/degradation of the microorganisms non-adapted to intracellular life (Figure [1](#F1){ref-type="fig"}). Not surprisingly, lysosome-related genes (enzymes and transport proteins) have been associated to survival in oysters infected with virulent *Vibrio* strains (de Lorgeril et al., [@B20]). On the opposite, as far as intravacuolar pathogens are concerned, the success of infection appears to rely on a restricted respiratory burst and/or the development of mechanisms of resistance to the oyster antimicrobial response. This has been observed for two oyster pathogens, *V. splendidus* and *Perkinsus marinus*, which resist to intracellular elimination after phagocytosis (Schott et al., [@B105]; Duperthuy et al., [@B24], [@B25]).

Effectors of the Antimicrobial Response
=======================================

Production of reactive oxygen species
-------------------------------------

Immediately following phagocytosis, there is a significant increase in the intracellular oxygen consumption (respiratory burst), resulting in the production of a variety of intermediate reactive oxygen species (ROS) (Bachère et al., [@B4]; Torreilles and Romestand, [@B114]; Lambert et al., [@B65], [@B66]).

The production of ROS (superoxides and peroxides) is one major inducible mechanism of the antimicrobial response in oysters (Bachère et al., [@B4]; Lambert et al., [@B65]). It results from the activation of the transmembrane NADPH oxidase, which generates the highly toxic and reactive superoxide anion $\text{0}_{\text{2}}^{-}$. The production of ROS can cause serious injuries to the host tissues. Interestingly, parallel to the well known NADPH oxidase, a sequence homologous to another transmembrane enzyme termed DUOX for (DUal OXidase) involved in the production of ROS in *Drosophila melanogaster* gut epithelial cells was evidenced in the *C. gigas* genomic resource database (Fleury et al., [@B28]). In *C. gigas*, the expression of a DUOX-like gene was associated, together with other genes related to oxidative stress, to a successful response to virulent vibrios as compared to avirulent vibrios (de Lorgeril et al., [@B20]). Interestingly, DUOX expression was shown to be involved in the tolerance of resident microflora in the gut of *Drosophila* and to be over expressed when the gut bacterial load dramatically increases (for review see Royet, [@B97]). Therefore, as in *Drosophila*, DUOX, which is expressed in the digestive gland of oysters, could be involved in the epithelial defense against food-borne pathogens and in the maintenance of homeostasis.

To avoid self-damage, the host relies on effective antioxidant defense systems that involve antioxidant enzymes such as a superoxide dismutase (SOD), which converts $\text{0}_{\text{2}}^{-}$ into hydrogen peroxide H~2~0~2~, and peroxidases (catalase and glutathione peroxidase), which convert H~2~0~2~ into hypochlorous acid in the presence of chloride ions. As a sign of its contribution to an effective immune response in oysters, the *C. gigas* extracellular SOD was shown to be higher expressed in an oyster line selected for its resistance to *in situ* mortalities than in a susceptible line (Fleury and Huvet, [@B27]). It was also higher expressed in oysters surviving an infection with virulent *Vibrio* strains than in oysters challenged with avirulent vibrios (de Lorgeril et al., [@B20]). Other antioxidant enzymes are also produced in oysters such as peroxiredoxins, glutathione *S*-transferases, and others (Huvet et al., [@B48]; Tanguy et al., [@B109]; Vertuani et al., [@B117]; Gonzalez et al., [@B37]; Jo et al., [@B57]; Green et al., [@B38]; Park et al., [@B88]; Itoh et al., [@B51]; Yu et al., [@B127]). As with *Cg-EcSOD*, transcripts of glutathione S-transferases (microsomal glutathione S-transferase, glutathione S-transferase theta and omega class glutathione S-transferase) were more abundant in hemocytes of oysters capable to survive an injection with virulent *Vibrio* strains than in oysters challenged with an avirulent *Vibrio* strain (de Lorgeril et al., [@B20]).

Hydrolytic enzymes
------------------

After phagocytosis, microorganisms are entrapped in phagosomes that fuse with lysosomes and/or intracellular granules. These granules are characterized by their acidic pH and the presence of a wide variety of hydrolytic enzymes and antimicrobial effectors (Figure [1](#F1){ref-type="fig"}). Among the hydrolytic enzymes, the lysozymes play an important role in microbial destruction due to their lytic properties on the peptidoglycan of the bacteria cell wall (Hancock and Scott, [@B44]). Oyster lysozymes form a diverse group and are expressed in many tissues, such as hemocytes (CGL-1 or *Cg*\_lysoz1), digestive diverticula (CGL-2 or *Cg*\_lysoz2), and mantle (CGL-3 or *Cg*\_lysoz3) (Matsumoto et al., [@B79]; Itoh and Takahashi, [@B52]; Itoh et al., [@B55], [@B50]; Xue et al., [@B121]). In hemocytes, lysozyme transcript abundance was shown to be higher in oysters capable to survive an injection of virulent *Vibrio* strains than in oyster challenged with an avirulent *Vibrio* (de Lorgeril et al., [@B20]). Recombinant lysozymes from *C. gigas* (CGL-1 and CGL-3) were found to be active only against Gram-positive bacteria (Itoh et al., [@B50]).

Antimicrobial peptides and proteins
-----------------------------------

Antimicrobial peptides and proteins (AMPs) are key host defense effectors found in virtually all kingdoms of life (Yeaman and Yount, [@B125]). They display multifunctional roles in immunity, including microbicidal activities and selective immunomodulatory effects (Yount et al., [@B126]; Guaní-Guerra et al., [@B39]). AMPs are classically described as small cationic (less than 10 kDa), amphipathic, gene-encoded peptides that differ considerably in amino acid sequence and structural conformation (Bulet et al., [@B12]; Brogden, [@B9]). Several categories of AMPs have been described based on common structural features or conserved sequence motifs. More recently, other groups of antimicrobial molecules referred to as "non-conventional" have been identified that do not fit into this classical definition. These are (i) anionic peptides, (ii) cationic proteins larger than 10 kDa, and (iii) multifunctional proteins that contain antimicrobial sub-domains that are cleaved under certain conditions and generate fragments that behave as antimicrobial peptides (Brogden, [@B9]; Yount et al., [@B126]). At present, several families of AMPs or polypeptides sharing common molecular features with the currently known AMP families have been characterized in oysters. These include defensin-like peptides (defensins and big defensins), proline-rich AMPs, and BPI proteins (Table [1](#T1){ref-type="table"}).

###### 

**Oyster antimicrobial peptides and proteins (AMPs)**.

  Oyster AMP                                     Variants       MW (kDa)   p*I*   Localization (expression)
  ---------------------------------------------- -------------- ---------- ------ ---------------------------
  CSαβ-containing defensins                      *Cg*-Defm      4.6        8.7    Mantle (constitutive)
                                                 *Cg*-Defh1     4.7        8.5    Hemocytes (constitutive)
                                                 *Cg*-Defh2     4.6        8.5    Hemocytes (constitutive)
  Big defensins                                  *Cg*-BigDef1   10.7       9.2    Hemocytes (inducible)
                                                 *Cg*-BigDef2   9.8\*      8.6    Hemocytes (inducible)
                                                 *Cg*-BigDef3   9.7\*      8.8    Hemocytes (constitutive)
  Proline-rich peptides                          *Cg*-lgPrp     1.8\*      12.1   Hemocytes (repressed)
                                                 *Cg*-stPrp     1.5\*      12.0   Hemocytes (repressed)
  Bactericidal/permeability-increasing protein   *Cg*-BPI       50.1       9.3    Hemocytes (inducible)
                                                                                  Epithelia (constitutive)

*MW: observed or theorical (\*) molecular weight; p*I*: theoretical isoelectric point*.

### Structure and classification of *C. gigas* AMPs

#### Defensins

Defensins were identified in most plants, fungi, and both invertebrate and vertebrate animals (Bulet et al., [@B12]). They are the best characterized AMPs to date. The term "defensin" was first introduced by Ganz et al. ([@B30]) after the discovery of antimicrobial cysteine-rich peptides in human neutrophils. All vertebrate defensins are small (3--5 kDa) cationic molecules containing six cysteine residues engaged in three intramolecular disulfide bridges. Vertebrate defensin family falls into three subfamilies, namely the open-ring α- and β-defensins as well as the head-to-tail θ-defensins, which differ in terms of cysteine array and secondary structure (for review see Lehrer and Lu, [@B71]). Thus, the cysteine pairing of β-defensins differs from that of α- and θ-vertebrate defensins.

Unlike vertebrate defensins, which adopt a three-stranded antiparallel β-sheet structure, the defensins from plants, fungi, and invertebrates are composed of an α-helix linked to an antiparallel two-stranded β-sheet by disulfide bridges, making the so-called cysteine-stabilized α-helix/β-sheet motif (CSαβ; Zhu et al., [@B130]). They contain from six to eight cysteine residues. This motif is widespread in fungi and in invertebrate defensins, like in arthropods and mollusks (Yang et al., [@B124]; Bulet and Stöcklin, [@B11]; Mygind et al., [@B83]), but the presence of eight cysteine residues was only reported in species of bivalve mollusks (Hubert et al., [@B47]; Gueguen et al., [@B41]; Gonzalez et al., [@B35]). CSαβ-containing defensins have no evident phylogenetic relationships with the vertebrate defensins and big defensins (Rosa et al., [@B94]).

#### CSαβ-containing defensins (Cg-Defs)

In *C. gigas*, members of the invertebrate CSαβ-containing defensin family were identified by screening EST libraries of oyster immune cells (hemocytes and surface epithelia). A broad diversity of CSαβ-containing defensins was found in *C. gigas* (see diversity section below). Still, three representative members, namely *Cg*-Defm, *Cg*-Defh1, and *Cg*-Defh2, were characterized in more details in terms of structure, antimicrobial activity, and mechanism of action. *Cg*-Defm was identified from the oyster mantle whereas *Cg*-Defh1 and *Cg*-Defh2 were identified from the hemocytes (Gueguen et al., [@B41]; Gonzalez et al., [@B35]). All oyster defensin precursors consist in a hydrophobic signal peptide (prepeptide) immediately followed by the 4.6--4.7-kDa cationic mature peptide (p*I* 8.5--8.7), which contains eight cysteine residues (Figure [2](#F2){ref-type="fig"}). The tridimensional structure of the recombinant *Cg*-Defm was solved (PDB: 2B68; Figure [3](#F3){ref-type="fig"}), showing that the CSαβ motif that characterizes this AMP family is stabilized by four disulfide bridges (cysteine pattern: C~1--5~C~2--6~C~3--7~C~4--8~; Gueguen et al., [@B41]; Table [1](#T1){ref-type="table"}). The fourth disulfide bridge, only found in oyster and mussel defensins, has been proposed to be implicated in the stabilization of the mature peptide to the high osmolarity environment found in the sea water (Yang et al., [@B124]).

![**Amino acid alignment of oyster antimicrobial precursors with similar proteins/polypeptides from other species**. *Cg*-Def precursors are composed of a 22-residue signal peptide followed by a 43-residue mature peptide. By comparison, the *Mytilus galloprovincialis* MGD2 (GenBank AAD45118.1) carries an additional anionic proregion at C-terminal position. The amino acid sequences displayed here for *Cg*-Defm, *Cg*-Defh1, and *Cg*-Defh2 correspond to GenBank AJ565499, ACQ73009, and ACQ76280, respectively. The cysteine array is based on the 3D structure of *Cg-*Defm (PDB: 2B68). *Cg-BigDef* precursors are composed of a predicted signal peptide (23 residues) followed by 13-residue anionic proregion and the putative mature BigDefs (87--94 residues). Mature BigDefs are multi-domain polypeptides composed of a hydrophobic N-terminal domain (I) and a C-terminal cysteine-rich domain (β-defensin-like domain, II) shown here as orange boxes. A putative cleavage motif (RXKR) for furin-like enzymes separates both domains. Sequences of big defensins from *Crassostrea gigas* (Cg-BigDef1: GenBank AEE92768, Cg-BigDef2: GenBank AEE92775, Cg-BigDef3: GenBank AEE92778) are aligned here with *Tachypleus tridentatus* big defensin (BDEF_TACTR, GenBank: P80957). The cysteine array is based on the 3D structure of the horseshoe crab big defensin (PDB: 2RNG). *Cg-BPI* precursor is composed of a 19-residue signal peptide followed by a 458 amino acid protein. Its amino acid sequence (GenBank AY165040) is aligned here with human BPI (hBPI) sequence (GenBank J04739). The *N-*terminal (domain I) and *C-*terminal (domain II) barrel type domains characterized for hBPI as well as the corresponding sequences in *Cg-*BPI are in orange boxes (domains I and II, respectively). The proline-rich central domain is boxed with a dashed line. The three functional regions of hBPI, which display LPS-binding activity, are highlighted in gray. The conserved disulfide bridge characterized in hBPI 3D structure (PDB: 1BP1) is displayed. Amino acids are numbered on the right. Signal peptides are underlined. Cysteines are highlighted in black and disulfide bridges are displayed as black lines. Conserved residues are shown by an asterisk. Lys/Arg residues are in blue. Asp/Glu residues are in red. Positively and negatively charged residues conserved in more than 50% of the sequences are highlighted in blue and red, respectively. In *Cg*-Def and *Cg*-BigDef alignments, anionic proregions are in dashed boxes. In *Cg*-BPI alignment, the central proline-rich region is in dashed boxes.](fmicb-03-00160-g002){#F2}

![**Solution structure of *Cg*-Defm (PDB: 2B68)**. *Cg-*Defs display the CSαβ motif also found in defensins from plants, fungi, and invertebrates, which is composed of an α-helix (red) linked to an antiparallel two-stranded β-sheet (blue) by disulfide bridges (yellow). In *Cg*-Defs, eight cysteines are involved in four disulfide bridges as follows: C~1--5~C~2--6~C~3--7~C~4--8~.](fmicb-03-00160-g003){#F3}

Each *Cg*-Def is encoded by a separate gene with different genomic organization. The mantle defensin genes (*Cg-defm*) present two structures (i) two exons separated by a unique intron (Gueguen et al., [@B41]), a similar genomic organization to that of the mussel and scorpion defensin genes (Froy and Gurevitz, [@B29]), and (ii) three exons separated by two introns. Hemocyte defensin genes (*Cg-defhs*) only display the latter structure, in which the second intron separates the two last residues of the mature peptide apart from the rest of the sequence (Schmitt et al., [@B103]). The number of *Cg-def* gene copies was shown to be highly variable (14--53 copies) among individual oysters (Schmitt et al., [@B103]). At the transcriptional level, *Cg*-Defs appear to be constitutively expressed in each specific tissue.

Until now, native defensins could not be purified from *C. gigas* oysters in sufficient amounts to enable complete biochemical characterization and determine their spectrum of activity. Such data were obtained with recombinant oyster defensins (Gueguen et al., [@B41]; Schmitt et al., [@B104], [@B101]). All oyster defensins were shown to be mainly active against Gram-positive bacteria against which they displayed very low minimal inhibitory concentrations (MIC; 0.01--6 μM) as determined by liquid growth inhibition assay. Conversely, they did not display significant antimicrobial activity against Gram-negative bacteria including oyster pathogens (\>40 μM).

#### Big defensins (Cg-BigDefs)

Big defensins (BigDefs) are antimicrobial polypeptides that were initially purified from the hemolymph cells (amoebocytes) of the horseshoe crab *Tachypleus tridentatus* (Chelicerata; Saito et al., [@B99]). The solution structure of the horseshoe crab BigDef (PDB: 2RNG) revealed a N-terminal globular domain connected to a C-terminal domain containing β-sheet structures and folded by three disulfide bridges whose arrangement is identical to that of vertebrate β-defensins (β-defensin domain: C~1--5~C~2--4~C~3--6~; Kouno et al., [@B59]). The horseshoe crab BigDef is produced as a precursor molecule that is further processed into a 8.6-kDa mature polypeptide (Saito et al., [@B99]). Big defensin encoding sequences were also evidenced in amphioxus (Cephalochordata) and in several mollusk species including *C. gigas* oysters (for review see Rosa et al., [@B94]). Oyster big defensins (*Cg*-BigDefs) share 47--55% amino acid sequence identity with the big defensin from horseshoe crab and amphioxus species, and within mollusks, they are 25--28% identical to gastropod sequences and 39--67% identical to bivalve big defensins (Rosa et al., [@B94]).

Oyster big defensins form a diverse AMP family composed of three representative members, namely *Cg*-BigDef1, *Cg*-BigDef2, and *Cg*-BigDef3. Big defensin precursors are expressed as prepropeptides, which start with a predicted 23-residue signal peptide (prepeptide), followed by a propeptide region of 13 residues and a cationic 94- or 87-residue mature polypeptide of 10.7 kDa (*Cg*-BigDef1), 9.8 kDa (*Cg*-BigDef2), or 9.7 kDa (*Cg*-BigDef3; Table [1](#T1){ref-type="table"}). The mature polypeptides have theorical *pI* ranging from 8.6 to 9.2. Based on mass spectrometry data, it has been proposed that after elimination of the, the N-terminal glutamine residue of the native *Cg*-BigDef1 is converted into a pyroglutamic acid (Rosa et al., [@B94]). *Cg*-BigDefs are chimeric molecules that display the structural feature of the horseshoe crab BigDef composed by a hydrophobic N-terminal region and a cationic C-terminal region containing the conserved six cysteine residues (Figure [2](#F2){ref-type="fig"}).

Each of the three *Cg*-BigDefs is encoded by a separate gene whose expression is restricted to hemocytes, both circulating and infiltrating oyster tissues. The genomic organization of *Cg-bigdef1* and *Cg-bigdef2* genes is similar, with two exons interrupted by a single intron. In contrast, in *Cg-bigdef3*, additional intron and exon are observed upstream the first exon common to the other *Cg-bigdefs*. In all *Cg-bigdef* genes, the β-defensin domain is exclusively encoded by the last exon (Rosa et al., [@B94]).

The antimicrobial activities of *Cg*-BigDefs are still unknown, but in another bivalve mollusk, *Argopecten irradians*, and in the horseshoe crab *T. tridentatus*, BigDefs were reported to be active against both Gram-positive and Gram-negative bacteria and fungi (Saito et al., [@B99]; Zhao et al., [@B129]). Besides, the native horseshoe crab BigDef was shown to display a significant LPS-binding activity (Saito et al., [@B99]).

#### Proline-rich AMPs (*Cg*-Prps)

Like defensins, proline-rich AMPs (Prps) have been identified in vertebrates including mammals and amphibians as well as invertebrates such as insects and crustaceans (Scocchi et al., [@B107]). They form a group of diverse peptides that share some structural features, like a high content in proline and arginine residues (typically from 25 to 50%). They display short Pro-Arg-Pro motifs, which have been proposed to be implicated in their antimicrobial activity. Prps are also characterized by their mode of action, which does not involve the lysis of bacterial membranes but rather the penetration into cells, where they then act intracellularly (Scocchi et al., [@B107]).

In oysters, a cDNA sequence showing homologies to proline-rich AMPs was identified as expressed in hemocytes by the exploration of *C. gigas* EST libraries (Gueguen et al., [@B42]). The cDNA sequence encoded a 37-amino acid peptide, which is composed of an N-terminal acidic region (putative propeptide) and a C-terminal cationic proline-rich region, containing two repetitions of a Pro-Arg-Pro motif (Figure [4](#F4){ref-type="fig"}). This highly cationic peptide (theorical *pI* 12.1), which displays the typical features of proline-rich AMPs, was named *Cg*-Prp. A high number of *Cg*-Prp forms were then identified as expressed by oyster hemocytes. They display two lengths, a shorter peptide being evidenced, which derives from the original *Cg*-Prp form by the deletion of a Arg-Pro dipeptide (Schmitt et al., [@B103]). Thereby, we renamed the original form as long *Cg*-Prp (*Cg*-lgPrp; 1.8 kDa) and the new form as short *Cg*-Prp (*Cg*-stPrp; 1.5 kDa) (Schmitt et al., [@B101]; Table [1](#T1){ref-type="table"}; Figure [4](#F4){ref-type="fig"}).

![**Amino acid alignment of two sequences representative of long and short *Cg*-Prps**. Precursors of *Cg*-Prps are composed of a 24-residue signal peptide (underlined) followed by a 19-residue anionic proregion (dashed box), and a 16--18 residue putative mature peptide. In long forms (referred to as *Cg*-lgPrps), two repeats of the Pro-Arg-Pro motif (orange boxes) are found, while in short forms (*Cg*-stPrps), one motif is missing. While Pro-Arg-Pro motifs are common in proline-rich AMPs across species, no further structure similarity has been evidenced until now between oyster Prps and other proline-rich peptides. The amino acid sequences displayed here for *Cg*-lgPrp and *Cg*-stPrp correspond to GenBank FJ669361 and FJ669381, respectively. Amino acids are numbered on the right. Conserved residues are shown by an asterisk. Conserved Lys/Arg and Asp/Glu residues are highlighted in blue and red, respectively. Pro residues are shown in green.](fmicb-03-00160-g004){#F4}

*Cg*-Prps are a multigenic family with genes containing or not an intron. The presence/absence of an intron is observed in the genes encoding both the long and short peptide forms. The number of *Cg-prp* gene copies was shown to vary among individuals from 4 to 18 copies (Schmitt et al., [@B103]).

Native *Cg*-Prps could not be purified from oyster hemocyte extracts until now. Therefore, synthetic *Cg*-Prps were used to explore their sprectrum of antimicrobial activity. Both long and short *Cg*-Prps were poorly active against Gram-positive bacteria and were not active against Gram-negative bacteria. However, *Cg*-lgPrp displayed strong synergy with *Cg*-Defs and *Cg*-BPI against both Gram-positive and Gram-negative bacteria (Gueguen et al., [@B42]; Schmitt et al., [@B101]).

#### Bactericidal/permeability-increasing protein (*Cg*-BPI)

Bactericidal/permeability-increasing proteins and lipopolysaccharide-binding proteins (LBPs) are components of the immune system that have been mainly characterized in mammals. Both proteins show 45% sequence identity, sharing basic structural features and residues involved in LPS-binding (Krasity et al., [@B62]). Human LBP is an acute phase plasma protein constitutively secreted by liver that induces cellular responses (Thomas et al., [@B113]). In particular, LBP participates in the acute mobilization of circulating neutrophils to sites of tissue injury. In contrast, human BPI is a 55-kDa cationic protein specifically active against Gram-negative bacteria. Stored in neutrophils, human bactericidal/permeability-increasing (hBPI) contributes to the elimination of bacteria and increases the permeability of the bacterial membranes (Levy, [@B73]). Accumulated extracellularly, it also opsonizes bacteria, enhancing neutrophil phagocytosis (Iovine et al., [@B49]). The antibacterial BPI also displays LPS-neutralizing properties and suppresses LPS inflammatory activity (Weiss, [@B119]). By genomic approaches, LBP/BPI-related genes have been found in a number of non-mammalian vertebrate species and several invertebrates like nematodes and mollusks (Krasity et al., [@B62]).

A homolog of the hBPI protein was identified in *C. gigas* oysters by a screening of a hemocyte EST library (Gonzalez et al., [@B36]). As deduced by molecular modeling, *Cg*-BPI displays the typical structural features of hBPI 3D structure (PDB: 2RNG) with an N- and C-terminal β-barrel type domains connected by a proline-rich central domain. In addition, the N-terminal domain of *Cg*-BPI contains the LPS-binding regions characterized in hBPI and the Lys and Arg residues required for LPS-binding. This domain also contains the cysteine bridge of hBPI at conserved position, three extra cysteines being identified (both in the N- and C-terminal domains) whose folding remains unknown. The recombinant *Cg*-BPI was shown to be a monomeric protein (50.1 kDa) and to display both LPS- and Lipid A-binding activities (Gonzalez et al., [@B36]). It was highly active against the short-chain LPS *E. coli* SBS363, against which it displayed bactericidal activity, but was at least 30 times less active against the long-chain LPS *E. coli* ML35. Like hBPI, recombinant *Cg*-BPI permeabilized both the inner and outer membranes of *E. coli* ML35 (Gonzalez et al., [@B36]). Like *Cg*-BPI, the recently identified *Cg*-BPI2 was also shown to be exclusively active against Gram-negative bacteria (Zhang et al., [@B128]).

#### Diversity of oyster antimicrobial peptides

High levels of sequence diversity were reported to be a characteristic of several genes belonging to the innate immunity system of invertebrates (Schulenburg et al., [@B106]). Similarly, oyster families of antimicrobials were recently shown to be highly diverse (Schmitt et al., [@B103]). Phylogenetic analyses showed that *Cg*-Defs are represented by three distinct groups, of which *Cg*-Defh1, *Cg*-Defh2, and *Cg*-Defm forms are the most representatives. *Cg*-Prp is represented by two major forms, *Cg*-lgPrp and *Cg*-stPrp, but its phylogeny showed more diverse groups of sequences and suggested an ongoing or recent process of neo- or sub-functionalization (Schmitt et al., [@B103]). In contrast to both AMPs, *Cg-*BPI was mostly represented by the only one sequence originally identified, but the recently discovery of *Cg-*BPI2 suggests a higher diversity for this antimicrobial (Zhang et al., [@B128]). Additionally, the *in silico* analysis of the oyster EST database (<http://www.sigenae.org/aquafirst/>) revealed that *Cg-*BigDefs are a diverse family with several isoforms for the three *Cg*-BigDef1, -2, and -3 forms (Rosa et al., [@B94]).

Evolutionary analyses showed that *Cg*-Defs and *Cg*-Prps have been subjected to several genetic mechanisms of diversification and that directional selection pressures have shaped their sequence variations. Noteworthy, directional selection driving evolution of invertebrate immune system has been addressed for several genes (Cohuet et al., [@B18]; Lazzaro, [@B69]; Roger et al., [@B93]) and it has been related with the general hypothesis of co-evolution or "arms race" between host and pathogens (Van Valen, [@B116]).

Specifically, the diversification of AMPs by the accumulation of multiple variants around an initial form has been previously associated to the gain of specific antimicrobial functions (Litman et al., [@B75]; Rosenfeld and Shai, [@B96]; Yang et al., [@B123]). Notably, it has been shown that the different forms of each oyster AMP family could display different antimicrobial potency (Schmitt et al., [@B101]). The long *Cg*-Prp forms, which display an extra Pro-Arg-Pro motif in the active region are more potent that the short forms (Schmitt et al., [@B101]). When referring to *Cg*-Defs, although the three forms show a similar spectrum of activity, they display different potency against Gram-positive bacteria. In particular, *Cg*-Defh2 is the most potent, showing MIC values 2- to 40-fold lower than *Cg*-Defh1 and *Cg*-Defm against most of the Gram-positive strains tested (Table [2](#T2){ref-type="table"}; Schmitt et al., [@B103], [@B101]). Interestingly, the differences in potency are much higher against the marine strain *B. stationis* (40-fold) than against all other bacteria tested (less than eightfold), which unlikely belong to the oyster environmental microflora and have unlikely co-evolved with the oyster immune system. These evidences tempt us to hypothesize that the diversity of oyster AMPs may have been shaped by the co-evolution between the oyster immune system and species of oyster pathogens, generating new AMP variants with enhanced potency. In support of this hypothesis, the more active defensin forms, *Cg*-Defm and *Cg*-Defh2, display a charged residue under positive selection (Lys and Arg, respectively) where *Cg*-Defh1 displays an uncharged Gly. Because those residues are highly exposed at the surface of oyster defensins, it was inferred they could improve defensin antibacterial activity by promoting a better binding to bacterial membranes. Therefore, as far as oyster defensins are concerned, diversifying selection is affecting charge distribution, which is known as one major determinant of antimicrobial activity in AMPs. Thus, although solid evidences are still missing in oysters, the selection of specific repertoires of AMPs with enhanced activity may have consequences on the oyster capacity to survive infections, as proposed in other species (Tennessen et al., [@B112]).

###### 

**Antimicrobial activities of *Cg*-Defs, *Cg*-Prps, and *Cg*-BPI against selected microorganisms**.

  MIC (μM)                                   *Cg-*Defh2   *Cg-*Defm   *Cg-*Defh1   *Cg*-lgPrp   *Cg-*stPrp   *Cg-*BPI
  ------------------------------------------ ------------ ----------- ------------ ------------ ------------ ----------
  **GRAM-POSITIVE BACTERIA**                                                                                 
  *Micrococcus lysodeikticus* CIP5345        0.01         0.01        0.03         80           \>80         \>20
  *Bacilllus megaterium* CIP 6620            0.03         0.03        0.06         20           \>20         nt
  *Staphylococcus aureus* CIP 103428         0.25         2           2            \>20         \>20         nt
  *Staphylococcus aureus* SG511              0.12         0.25        0.5          \>20         \>20         nt
  *Microbacterium maritypicum* CIP 105733T   1            1           2            \>20         \>20         nt
  *Brevibacterium stationis* CIP 101282      0.1          0.2         4            \>20         \>20         nt
  *Staphylococcus haemolyticus*              2            2           6            \>20         \>20         nt
  **GRAM-NEGATIVE BACTERIA**                                                                                 
  *Escherichia coli* SBS 363                 20           20          40           \>80         \>80         0.7
  *Vibrio splendidus* LGP32 CIP 107715       \>40         \>40        \>40         \>40         \>40         10
  *Vibrio aestuarianus* LPi 02/41            \>40         \>40        \>40         nt           nt           nt
  *Vibrio anguillarum* ATCC 19264            \>40         \>40        \>40         nt           nt           nt
  *Vibrio nigripulchritudo* CIP103195        \>40         \>40        \>40         \>40         \>40         nt
  **FILAMENTOUS FUNGI**                                                                                      
  *Fusarium oxysporum*                       nt           9           nt           \>200        nt           0.7
  *Botrytis cinerea*                         nt           \>20        nt           \>200        nt           nt
  *Penicillium crustosum*                    nt           \>20        nt           nt           nt           nt

*MIC values (μM) refer to the minimal inhibitory concentration required to achieve 100% growth inhibition. nt: not tested. Modified from Gueguen et al. ([@B41]), Schmitt et al. ([@B104])*.

### Mechanisms of antimicrobial action and synergism

The mechanisms of action of antimicrobial peptides have been extensively reviewed. Many families of AMPs, which carry a positive net charge and adopt an amphipathic structure, have been shown to be membrane-disruptive. Their physicochemical properties determine their initial electrostatic interaction with the negatively charged bacterial membranes and further insertion into the bacterial membrane lipid bilayer. Several models have been proposed for membrane-disruptive mechanisms of action, ranging from pore formation to detergent-like activities (for review see Brogden, [@B9]). Still, not all antimicrobials are membrane-disruptive and alternative mechanisms of action are increasingly described in which intracellular molecules involved in vital processes (e.g., enzymes, precursors ...) are the target of AMPs. Among others, such non-lytic mechanisms of action have been reported in proline-rich AMPs (Scocchi et al., [@B107]) as well as in CSαβ defensins (Wilmes et al., [@B120]). The mechanism of action and consequently the target specificity of oyster antimicrobials are very diverse. At present, *Cg-*Defs and *Cg-*BPI are the best described oyster antimicrobials in terms of mechanisms of action.

*Cg*-Defs are potent inhibitors of the peptidoglycan biosynthesis in Gram-positive bacteria, against which they display strong antibacterial activity (in the nanomolar range). As shown on strains of *Staphylococcus aureus*, antibacterial activity is observed in absence of membrane disruption and results from the high affinity binding of *Cg-*Defs to the cell wall precursor lipid II, which cannot be further incorporated into peptidoglycan biosynthesis and accumulates in the bacterial cytoplasm (Schmitt et al., [@B104]). Interestingly, at high concentrations (10 μM and above), *Cg-*Defs can also present membrane-disruptive properties as observed against the Gram-negative *V. splendidus* LGP32 (Duperthuy et al., [@B24]).

*Cg*-BPI, as a member of the BPI family, was shown to be both bactericidal and membrane-permeabilizing against Gram-negative bacteria. Its mechanism of action was mainly studied on *E. coli* strains. Bactericidal activity (loss of culturability) against *E. coli* SBS363 was recorded at 1 μM. Besides, a dose-dependent inner membrane permeabilization was evidenced by the extracellular cleavage in a lactose-permease deficient strain (*E. coli* ML35) of a β-galactosidase (a cytoplasmic enzyme) substrate (Gonzalez et al., [@B36]).

*Cg-*Prps and *Cg-*BigDefs remain poorly studied in terms of mechanism of action. It can be speculated that, like many proline-rich AMPs (Kragol et al., [@B61]; Otvos, [@B86]; Scocchi et al., [@B107]), *Cg*-Prps interact with intracellular targets in bacteria. Concerning big defensins, a mechanism of action was proposed for the horseshoe crab BigDef, which is based on the penetration of the hydrophobic N-terminal domain into the microbial cell membrane (Kouno et al., [@B60]).

As a result of their different mechanism of action, oyster antimicrobials show a diverse range of antimicrobial activities: *Cg*-Defs are mainly active against Gram-positive bacteria, *Cg*-Prps are barely active alone, and *Cg*-BPI is only active against Gram-negative bacteria. Noteworthy, the combination of oyster antimicrobials produces strong synergistic activities that enlarge their spectra of activity (Schmitt et al., [@B101]). Synergistic activities between oyster antimicrobials were evidenced between different families such as *Cg*-Defs and *Cg*-Prps (Gueguen et al., [@B42]) but also *Cg*-Defhs and *Cg*-BPI (Schmitt et al., [@B101]). Interestingly, synergies were also shown to occur between forms of the same AMP family, different potencies of synergism being observed (as measured through fractional inhibitory concentration \[FIC\] indexes) according to the combination of forms (Schmitt et al., [@B101]; Table [3](#T3){ref-type="table"}). It is therefore tempting to speculate that the production of a large number of structurally similar AMPs is evolutionary relevant in that it helps oyster antimicrobials cover a broader spectrum of antimicrobial activities through combinations of peptide isoforms which produce synergistic effects.

###### 

**Synergistic activities between *Cg*-Defs, *Cg*-Prps, and *Cg*-BPI against selected bacteria expressed as a fractional inhibitory concentration (FIC index\*)**.

  FIC index                 Gram-positive bacteria   Gram-negative bacteria   
  ------------------------- ------------------------ ------------------------ ------
  *Cg-*Defh1 + *Cg-*Defh2   0.50                     0.75                     0.75
  *Cg-*Defh1 + *Cg-*Defm    0.75                     0.75                     0.75
  *Cg-*Defh2 + *Cg-*Defm    0.37                     0.50                     0.50
  *Cg*-lgPrp + *Cg-*stPrp   2                        2                        2
  *Cg-*Defh1 + *Cg*-lgPrp   0.35                     0.50                     2
  *Cg-*Defh2 + *Cg*-lgPrp   0.30                     0.28                     2
  *Cg-*Defm + *Cg*-lgPrp    0.45                     0.75                     2
  *Cg-*BPI + *Cg*-lgPrp     nd                       0.50                     2
  *Cg-*BPI + *Cg-*stPrp     nd                       0.75                     2
  *Cg-*BPI + *Cg-*Defh1     0.45                     0.26                     2
  *Cg-*BPI + *Cg-*Defh2     0.23                     0.27                     2
  *Cg-*BPI + *Cg-*Defm      0.23                     0.31                     2

*Adapted from Schmitt et al. ([@B101])*.

*\*FIC index = \[A\]/MICA + \[B\]/MICB, where MICA and MICB are the MICs of peptides A and B alone and \[A\] and \[B\] are the MICs of peptides A and B in combination. The MICs for the peptides alone are as given in Table [2](#T2){ref-type="table"}. When MIC values are superior to the highest concentration we tested, we chose this value as the MIC in the calculation of the FIC index. FIC index were interpreted as follows: ≤0.5, strong synergy; 0.5−1 synergy; ≥1; additive effect; =2, no effect; ≥2, antagonism. nd, not determined*.

The mechanisms underlying the synergistic effects among members of a given family of antimicrobials, as evidenced for *Cg*-Defs and *Cg*-Prps (Schmitt et al., [@B101]), are still not understood. However, with the increasing knowledge on oyster antimicrobial mechanisms of action, a model can be proposed for the synergism between different families of antimicrobials. Thus, the combination of membrane-active antimicrobials such as *Cg*-BPI with non-lytic peptides such as *Cg*-Defs (and potentially *Cg*-Prps), which interact with an intracellular target, can be highly effective in terms of antimicrobial activity. Thus, *Cg*-BPI, which was shown to permeabilize bacterial membranes (Gonzalez et al., [@B36]), likely facilitates the access of *Cg*-Defs to their intracellular target (lipid II), in particular in Gram-negative bacteria where lipid II is located at both the inner and outer leaflets of the cytoplasmic membranes, protected from *Cg*-Def interaction by the inner and outer membranes. Although the existence of an intracellular target for *Cg*-Prps is still speculative, synergy with *Cg*-BPI could also rely on such a combination with a membrane-disruptive antimicrobial. As a consequence of synergism, the peptide concentrations required to kill bacteria are much lower than when peptides are acting alone.

### Regulation of AMP expression in healthy and diseased animals {#s1}

Oyster antimicrobials exhibit a wide variety of expression profiles in hemocyte populations and epithelia, which vary according to the families and the oyster health status. *Cg-*Defhs, *Cg*-Prps, and *Cg*-BigDef3 are expressed in hemocytes of healthy oysters. Besides, *Cg*-Defm and *Cg*-BPI are constitutively expressed in surface epithelia. While *Cg*-Defm is specifically expressed in the mantle, *Cg*-BPI is expressed in a broad series of tissues including mantle, gills, digestive tract, digestive gland diverticula, and gonad follicles. Comparatively, transcripts of *Cg*-BPI and *Cg*-BigDef1 and 2 are barely detected in hemocytes from healthy oysters (Gueguen et al., [@B41], [@B42]; Gonzalez et al., [@B35],[@B36]; Rosa et al., [@B94]; Schmitt et al., [@B101]).

After a microbial infection, each one of these antimicrobials follows a different pattern of gene expression. The expression of *Cg*-BPI as well as *Cg*-BigDef1 and 2 is strongly induced by a bacterial challenge in hemocytes, both circulating and infiltrating massively the oyster connective tissues of the gills, gonads, or digestive gland (Gonzalez et al., [@B36]; Rosa et al., [@B94]). On the opposite, *Cg*-Prp gene expression appears down-regulated in hemocytes upon a *Vibrio* infection (Schmitt et al., [@B101]). Based on immunocytochemistry data, *Cg*-BPI, *Cg*-Defhs, and *Cg*-Prps would be stored in cytoplasmic granules of oyster hemocytes (Gueguen et al., [@B42]; Schmitt et al., [@B101]). It is still unknown whether *Cg-*BigDefs are also stored in granules, as in horseshoe crab amoebocytes, or secreted into oyster hemolymph. In surface epithelia, genes encoding *Cg*-BPI as well as *Cg*-Defm remain constitutively expressed (Gueguen et al., [@B41]; Gonzalez et al., [@B36]). Whether the antimicrobials are stored or secreted remains to be established.

Interestingly, with the massive infiltration of given hemocyte populations at sites of infection, some AMPs constitutively expressed in oyster hemocytes show a decrease in transcript abundance in circulating hemocyte populations after a *Vibrio* challenge. Thus, it has been shown that upon injection of *V. splendidus* in the adductor muscle of oysters, *Cg*-Defh*-*expressing hemocytes migrate toward the damaged tissues as evidenced by the concomitant and significant increase of *Cg-*Defh transcript abundance at the *Vibrio* injection site (Schmitt et al., [@B101]). As a consequence, hemocytes seem to serve as a vehicle for given peptides like *Cg*-Defhs, driving them to tissues exposed to microorganisms where other peptides like *Cg*-Defm or *Cg*-BPI are constitutively expressed.

### How AMPs may participate in oyster defense

The constitutive expression of *Cg-*Defm and *Cg-*BPI in barrier epithelia of healthy oysters probably contributes to the control of their endobiont microbiota, which at a basal level could be beneficial for outcompeting potential pathogens from the environment. Indeed, in mammals, the constitutive expression of AMPs in tissues exposed to microbes regulates the numbers of colonizing microbes by creating an antimicrobial environment that prevents heavy colonization and helps to shape the composition of the colonizing microflora (Salzman et al., [@B100]; Duerkop et al., [@B22]; Bevins and Salzman, [@B7]).

Upon infection, additional families of AMPs expressed by hemocytes, namely *Cg-*BPI, *Cg*-BigDefs, and *Cg*-Defhs, are rapidly and massively colocalized in oyster tissues. While the constitutively expressed *Cg*-Defhs are transported through the migratory behavior of hemocytes, *Cg-*BPI, *Cg*-BigDef1 and 2 are massively transcribed in hemocytes infiltrating tissues (Rosa et al., [@B94]; Schmitt et al., [@B101]). This contributes to colocalize the antimicrobials which in turn can express synergism. As a consequence, by migration of antimicrobial-expressing hemocyte populations and continuous tissue expression, oyster antimicrobials are likely merged in tissues upon exposure to pathogens. For instance, the strong synergy observed between hemocyte defensins (*Cg*-Defh1 and 2) and mantle defensin (*Cg*-Defm) against the oyster pathogen *Vibrio splendidus* LGP32 (Table [3](#T3){ref-type="table"}) can only take place upon co-localization, which is dependent on hemocyte infiltration of the infected tissue.

Co-localization of oyster antimicrobials not only occurs in barrier epithelia but also in some populations of circulating hemocyte as demonstrated for *Cg*-Defhs and *Cg*-Prps on the one hand, and *Cg*-Defhs and *Cg-*BPI on the other hand (Gueguen et al., [@B42]; Schmitt et al., [@B101]). The subsequent synergism which potentially takes place could be of prime importance in the intracellular elimination of phagocytosed microorganisms. However, data are still missing on the behavior of hemocyte granules after infection. Do they fuse with the phagosome as described for human neutrophil defensins or are they exocytosed in the oyster plasma as shown for human cathelicidin LL-37? In other species of bivalve mollusks such as the mussel, in crustaceans, and in chelicerates, the contact with microorganisms or their cell wall components induces the degranulation of hemocytes and consequently the release of stored host defense molecules (Mitta et al., [@B81]; Muñoz et al., [@B82]; Kawabata, [@B58]). Comparatively, in insects, the gene expression and secretion of large amounts of AMPs is induced in epithelial cells and in the fat body by the presence of microorganisms (Hoffmann et al., [@B46]). Because *C. gigas* antimicrobial response seems to be highly based on phagocytic processes (Cheng, [@B14]; Hine, [@B45]; Takahashi and Mori, [@B108]), oyster AMPs could be involved in the elimination of invading pathogens during phagocytosis, as proposed for mussel mytilins (Mitta et al., [@B80]) and human neutrophil peptides (HNP; Ganz et al., [@B30]). Intracellularly, AMPs could act synergistically through the co-localization of diverse families and forms; they could also display antimicrobial activities in a coordinate manner with additional microbicidal reactions that involve lysosomial enzymes and ROS.

Unlike in many other marine invertebrates including species of bivalve mollusks, *C. gigas* AMPs are produced at low concentrations and have not been purified to homogeneity until now. Unsuccessful attempts to purify native oyster AMPs by the conventional biochemical methods normally used for the purification of cationic gene-encoded AMPs were documented (Bachère et al., [@B6]). Besides, after a bacterial challenge, increase of AMP concentration in plasma has never been reported. The lack of release of large amounts of AMPs within hemolymph upon infections greatly suggests the absence of a systemic humoral antimicrobial response in *C. gigas* oysters.

In summary, recent studies suggest that the production of a large number of AMPs within the same animal is an evolutionary strategy to increase the spectrum of antimicrobial activities by using combinations of peptide isoforms (Mangoni and Shai, [@B76]). Through the migratory properties of oyster hemocytes expressing diverse families of antimicrobials and the basal expression of antimicrobials in tissues, synergistic activities could take place and contribute to control microbial invasion. We propose that such a synergy, which was evidenced both within and between families of antimicrobials (Schmitt et al., [@B101]), is essential during the oyster immune response, and that the high degree of sequence diversity in oyster antimicrobials may compensate through synergic activities their low concentration in oyster tissues.

### How oyster pathogens evade the antimicrobial response

The continuous interplay between hosts and pathogens has evolved over millions of years. Thus, the success of a microbial infection or the achievement of host strategies to overcome diseases is a consequence of an active co-evolutionary process (Peschel and Sahl, [@B89]). In this way, pathogens have placed diverse mechanisms of resistance against antimicrobial responses. Particularly, several strategies are used by bacteria to evade host antimicrobials. They can resist AMPs by their inactivation by peptidases and proteases, or modify the net anionic charge of their cell envelope to reduce the affinity for AMPs; or even, AMPs can be actively extruded from bacterial cells (Yeaman and Yount, [@B125]).

Both commensals and pathogens are found in the hemolymph of oysters from which they can be isolated in a culturable state. Among them, many bacterial strains belong to the *Vibrio* genus (Gay et al., [@B33]). Interestingly, as commented above, the *C. gigas* plasma (cell-free hemolymph) is poor in antimicrobials. This could make oyster plasma adapted to bacterial life. Whether or not AMP-resistance is required for life in plasma is uncertain. However, in a recent study, one mechanism of AMP-resistance in vibrios, which is mediated by the major outer membrane protein OmpU (Mathur and Waldor, [@B78]; Mathur et al., [@B77]), was shown to endow the oyster pathogen *V. splendidus* LGP32 with (i) an increased resistance to oyster AMPs and (ii) a growth advantage in oyster plasma (Duperthuy et al., [@B24]).

While AMP-resistance mechanisms are still poorly documented in oyster pathogens, evasion of the cellular hemocyte reactions appears essentials. Indeed, both bacterial and protozoan parasites have developed strategies to avoid intracellular elimination by oyster phagocytes. Mechanisms of immune evasion have been reported in pathogenic strains of *P. marinus*, *V. splendidus*, and *V. aestuarianus* (Schott et al., [@B105]; Labreuche et al., [@B64], Duperthuy et al., [@B25]). Both *P. marinus* and *V. splendidus* invade oyster hemocytes as part of their pathogenic process. Therefore, after hemocyte invasion through subversion of hemocyte membrane receptors (galectins and β-integrins, respectively; Tasumi and Vasta, [@B111]; Duperthuy et al., [@B25]), they have developed strategies to resist to and/or suppress hemocyte defense reactions. Thus, *P. marinus* fails to elicit ROS production when entering hemocytes and displays intrinsic resistance to ROS (Schott et al., [@B105]). Similarly, *V. splendidus* LGP32 is able to manipulate phagosome maturation and to survive in oyster hemocytes by avoiding acidic vacuole formation and ROS production (Duperthuy et al., [@B25]). Although it is still unknown whether *V. splendidus* LGP32 invades hemocyte types that produce AMPs, by impairing phagosome maturation, it could prevent contact with host AMPs stored in hemocyte cytoplasmic granules.

Unlike *V. splendidus* LGP32, which is also associated to the summer mortality syndrome of oysters, *V. aestuarianus* strain 01/32 is described as an extracellular pathogen (Labreuche et al., [@B63]) and evades hemocyte reactions in a totally different manner. The evasion of *V. aestuarianus* 01/32 from oyster immune response relies on the avoidance of phagocytosis by the secretion of inhibitory extracellular products (ECPs; Labreuche et al., [@B63],[@B64]).

Thus, bacterial oyster pathogens have developed different strategies that can eventually reduce the probability to encounter oyster AMPs within the hemocytes. In addition, we have evidence that *Vibrio* spp. display high *in vitro* resistance to oyster AMPs (Duperthuy et al., [@B24]; Schmitt et al., [@B104]). From our current knowledge, such a resistance could be conferred by (i) the OmpU-mediated sensing of membrane perturbations and further signaling of the envelope stress response (Mathur and Waldor, [@B78]; Mathur et al., [@B77]), (ii) the VexAB-mediated efflux of AMPs (Bina et al., [@B8]), or (iii) other structural properties such as capsule formation that could also protect vibrios from the oyster antimicrobial response.

Conclusion
==========

Knowledge has been acquired on the antimicrobial response of the oyster over the past years. Still, much remains to be explored regarding its role in the oyster defenses and host--pathogen interactions. From our current knowledge, phagocytosis and the oxidative burst would be major reactions of the defense of *C. gigas* oysters against infections. Remarkably in this species, conventional AMPs such as those reviewed in the present article are found at very low concentrations in tissues. This is not a common feature in species of bivalve mollusks nor in invertebrates more generally. It is therefore reasonable to ask whether AMPs play a significant role in the oyster defense. In support of such a role are the major selective pressures that have been shown to shape AMP sequences at positions required for an efficient mechanism of action (electrostatic interactions with bacterial membranes, interaction with intracellular molecular targets ...). Still, there is no positive correlation evidenced between AMP expression and resistance to disease. We have shown here how the diversity of sequences and/or expression patterns of AMPs together with their co-localization in surface epithelia, which is mediated by hemocyte infiltration, can give rise to synergistic activities that likely contribute to the control of infections. We therefore believe that in this species, which lives in permanent contact with and is inhabited by a great variety of microorganisms, the diversity of AMPs may compensate for their scarcity in the regulation of the resident/pathogenic microflora, and as a consequence in the maintenance of oyster homeostasis. Future studies on the microbial communities that constitute the oyster microflora and their interaction with the oyster immune system will be required to better understand how oysters discriminate between commensal and pathogenic bacteria and to identify which host factors are involved in the regulation of this microflora.
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